Skip to main content

Advertisement

Log in

Use of a patient information leaflet to influence patient decisions regarding mode of administration of NSAID medications in case of acute low back pain

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Despite dissuasive recommendations, intramuscular (i.m.) injections of NSAIDS are still a widespread treatment of acute pain in General Practice as well as among orthopaedic physicians. Most physicians argue that patients who are used to receive NSAIDS i.m. would insist on this application mode while being convinced of its therapeutic superiority for pain relief. Therefore, the aim of the study was to find out if patients’ decision can be influenced towards an oral application by receiving a simple information leaflet. An information leaflet, providing information about the risks of NSAIDS particularly in case of i.m. application was provided to 161 patients with acute low back pain. Decision in favour or against i.m. application of NSAIDS was documented. Severity of disease was assessed by the Roland Morrison pain questionnaire and visual analogue scale (VAS) at the first visit and again 3–5 days later. From May to December 2004, 161 patients, visiting their GP (13 practices) with acute pain and demanding an injection were included in the study. After reading the information leaflet, 139 of the 161 (86.3%) patients decided for an oral application instead of receiving an injection of NSAIDS as in the past. This effect was statistically significant (P≤0.01). Of the initial 161 patients, 156 could be re-evaluated and no significant differences in the VAS and the Roland Morris Score between the patients with oral and i.m. application mode could be found. Only 2 patients of the 139 who decided for oral application indicated that they would opt for an i.m. injection next time. Our study demonstrates that patients’ decision can be influenced even in case of severe pain by providing adequate information on a short information leaflet. The results should help to reduce physicians’ fear of losing patients when not following their demand for i.m. injections and therefore enable a safer pain treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arzneimittelkommission der deutschen Ärzteschaft (2003) Kreuzschmerzen - Arzneiverordnung in der Praxis. Deutscher Ärzteverlag, Köln

  2. Becker A, Chenot JF, Niebling W, Kochen MM (2004) Guidelines for back pain. Z Orthop Ihre Grenzgeb 142(6):716–719

    Article  PubMed  CAS  Google Scholar 

  3. Braun RN (1956) Diagnosis in everyday practice. Dtsch Med Wochenschr 81(31):1236–1238

    Article  PubMed  CAS  Google Scholar 

  4. Brune K, Lanz B (1985) Pharmakokinetics of non-steroidal anti-inflammatory drugs. In: Bonta M, Bray MA, Parnham MJ (eds) Handbook of inflammation. Elsevier, Amsterdam, pp 413–449

    Google Scholar 

  5. Caudill-Slosberg MA, Schwartz LM, Woloshin S (2004) Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109(3):514–519

    Article  PubMed  Google Scholar 

  6. DEGAM (2004) Leitlinie Kreuzschmerzen. Omnikron publishing, Köln

    Google Scholar 

  7. Deyo RA, Weinstein JN (2001) Low back pain. N Engl J Med 344(5):363–370

    Article  PubMed  CAS  Google Scholar 

  8. Exner V, Keel P (2000) Measuring disability of patients with low-back pain—validation of a German version of the Roland & Morris disability questionnaire. Schmerz 14(6):392–400

    Article  PubMed  CAS  Google Scholar 

  9. Frick S, Cerny A (2001) Necrotizing fasciitis due to Streptococcus pneumoniae after intramuscular injection of nonsteroidal anti-inflammatory drugs: report of 2 cases and review. Clin Infect Dis 33(5):740–744

    Article  PubMed  CAS  Google Scholar 

  10. Gonzalez-Urzelai V, Palacio-Elua L, Lopez-de-Munain J (2003) Routine primary care management of acute low back pain: adherence to clinical guidelines. Eur Spine J 12(6):589–594

    Article  PubMed  Google Scholar 

  11. Grass H, Schuff A, Bertram C, Rothschild MA (2004) Intramuscular application of diclofenac—case report and critical consideration of a therapeutic measure. Z Orthop Ihre Grenzgeb 142(4):489–492

    Article  PubMed  CAS  Google Scholar 

  12. Hoeffler D, Schwabe U (2002) Letale Fasciitits necroticans nach gleichzeitiger i.m. Injektion von Diclofenac und Dexamethason. Arzneiverordnungen Prax (2):13

  13. Kenny T, Wilson RG, Purves IN et al (1998) A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use. Fam Pract 15(5):471–479

    Article  PubMed  CAS  Google Scholar 

  14. Koes BW, van Tulder MW, Ostelo R, Kim BA, Waddell G (2001) Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 26(22):2504–2513

    Article  PubMed  CAS  Google Scholar 

  15. Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R (2002) Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 324(7329):91–94

    Article  PubMed  Google Scholar 

  16. Mayrink M, Mendonca AC, da Costa PR (2003) Soft-tissue sarcoma arising from a tissue necrosis caused by an intramuscular injection of diclofenac. Plast Reconstr Surg 112(7):1970–1971

    Article  PubMed  Google Scholar 

  17. Pirmohamed M, James S, Meakin S et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15–19

    Article  PubMed  Google Scholar 

  18. Roberts L, Little P, Chapman J, Cantrell T, Pickering R, Langridge J (2002) The back home trial: general practitioner-supported leaflets may change back pain behavior. Spine 27(17):1821–1828

    Article  PubMed  Google Scholar 

  19. Rotman-Pikielny P, Levy Y, Eyal A, Shoenfeld Y (2003) Pyomyositis or “injectiositis”—Staphylococcus aureus multiple abscesses following intramuscular injections. Isr Med Assoc J 5(4):295–296

    PubMed  Google Scholar 

  20. Schabitz WR, Berger C, Knauth M, Meinck HM, Steiner T (2001) Hypoxic brain damage after intramuscular self-injection of diclofenac for acute back pain. Eur J Anaesthesiol 18(11):763–765

    Article  PubMed  CAS  Google Scholar 

  21. Scheppokat KD (2004) Medical errors and iatrogenic injury—results of 173 Schlichtungsstellen proceedings in general practice. Z Arztl Fortbild Qualitatssich 98(6):509–514

    PubMed  CAS  Google Scholar 

  22. Scheppokat KD (2005) Learning from the experiences as physician member of a German Schlichtungsstelle. Ther Umsch 62(3):185–190

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank all the participating doctors and patients. The project is part of PraxArt, financed by the German Ministry of Education and Research (BMBF), grant-number 01GK0301. The study was approved by the Ethical Commission of the University of Heidelberg. Approval Number: 139/2004.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Rosemann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosemann, T., Joos, S., Koerner, T. et al. Use of a patient information leaflet to influence patient decisions regarding mode of administration of NSAID medications in case of acute low back pain. Eur Spine J 15, 1737–1741 (2006). https://doi.org/10.1007/s00586-006-0068-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-006-0068-1

Keywords

Navigation